Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.
Conditional cell reprogramming for modeling host-virus interactions and human viral diseases.
复制标题
DOI:
10.1002/jmv.26093
复制
发表时间:
2020-11
影响因子:
12.7
通讯作者:
Mondal AM
中科院分区:
文献类型:
--
作者:
Liu X;Mondal AM
Conventional cancer and transformed cell lines are widely used in cancer biology and other fields within biology. These cells usually have abnormalities from the original tumor itself, but may also develop abnormalities due to genetic manipulation, or genetic and epigenetic changes during long‐term passages. Primary cultures may maintain lineage functions as the original tissue types, yet they have a very limited life span or population doubling time because of the nature of cellular senescence. Primary cultures usually have very low yields, and the high variability from any original tissue specimens, largely limiting their applications in research. Animal models are often used for studies of virus infections, disease modeling, development of antiviral drugs, and vaccines. Human viruses often need a series of passages in vivo to adapt to the host environment because of variable receptors on the cell surface and may have intracellular restrictions from the cell types or host species. Here, we describe a long‐term cell culture system, conditionally reprogrammed cells (CRCs), and its applications in modeling human viral diseases and drug discovery. Using feeder layer coculture in presence of Y‐27632 (conditional reprogramming, CR), CRCs can be obtained and rapidly propagated from surgical specimens, core or needle biopsies, and other minimally invasive or noninvasive specimens, for example, nasal cavity brushing. CRCs preserve their lineage functions and provide biologically relevant and physiological conditions, which are suitable for studies of viral entry and replication, innate immune responses of host cells, and discovery of antiviral drugs. In this review, we summarize the applications of CR technology in modeling host‐virus interactions and human viral diseases including severe acute respiratory syndrome coronavirus‐2 and coronavirus disease‐2019, and antiviral discovery.
登录
查看更多内容
影响因子:
3.7
作者:
Armstrong, Andrew J.;Gupta, Santosh;George, Daniel J.
通讯作者:
George, Daniel J.
影响因子:
3.7
作者:
Gardell AM;Qin Q;Rice RH;Li J;Kültz D
通讯作者:
Kültz D
DOI:
10.1002/pros.23206
发表时间:
2016-09
期刊:
The Prostate
影响因子:
--
作者:
Ellis L;Ku S;Li Q;Azabdaftari G;Seliski J;Olson B;Netherby CS;Tang DG;Abrams SI;Goodrich DW;Pili R
通讯作者:
Pili R
DOI:
10.1126/science.1254721
发表时间:
2014-12-19
期刊:
Science (New York, N.Y.)
影响因子:
--
作者:
Crystal AS;Shaw AT;Sequist LV;Friboulet L;Niederst MJ;Lockerman EL;Frias RL;Gainor JF;Amzallag A;Greninger P;Lee D;Kalsy A;Gomez-Caraballo M;Elamine L;Howe E;Hur W;Lifshits E;Robinson HE;Katayama R;Faber AC;Awad MM;Ramaswamy S;Mino-Kenudson M;Iafrate AJ;Benes CH;Engelman JA
通讯作者:
Engelman JA
DOI:
10.1165/rcmb.2016-0276ma
发表时间:
2017-05-01
影响因子:
6.4
作者:
Gentzsch, Martina;Boyles, Susan E.;Randell, Scott H.
通讯作者:
Randell, Scott H.